Breaking News Instant updates and real-time market news.

KEX

Kirby

$66.29 /

-0.96 (-1.43%)

04:55
05/12/21
05/12
04:55
05/12/21
04:55

Kirby management to meet virtually with Stephens

Virtual Meeting to be held on May 12 hosted by Stephens.

  • 12

    May

KEX Kirby
$66.29 /

-0.96 (-1.43%)

05/07/21 Gabelli
Kirby downgraded to Hold at Gabelli on decelerating earnings growth after 2023
05/07/21 Gabelli
Kirby downgraded to Hold from Buy at Gabelli
11/18/20 BofA
Kirby upgraded to Buy at BofA on refinery utilization increase potential
11/18/20 BofA
Kirby upgraded to Buy from Neutral at BofA

TODAY'S FREE FLY STORIES

Earnings
Dropbox reports Q2 EPS 40c, consensus 33c » 16:07
08/05/21
08/05
16:07
08/05/21
16:07
DBX

Dropbox

$31.59 /

+0.155 (+0.49%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DBX Dropbox
$31.59 /

+0.155 (+0.49%)

DBX Dropbox
$31.59 /

+0.155 (+0.49%)

06/10/21 RBC Capital
Dropbox assumed with an Outperform at RBC Capital
05/14/21 Goldman Sachs
Dropbox initiated with a Sell at Goldman Sachs
03/15/21 Jefferies
Dropbox price target raised to $31 from $28 at Jefferies
03/04/21 Citi
Citi adds Medallia to 'Value Creators' list, removes Dropbox
DBX Dropbox
$31.59 /

+0.155 (+0.49%)

DBX Dropbox
$31.59 /

+0.155 (+0.49%)

DBX Dropbox
$31.59 /

+0.155 (+0.49%)

DBX Dropbox
$31.59 /

+0.155 (+0.49%)

Earnings
CarParts.com reports Q2 EPS 4c, consensus (4c) » 16:07
08/05/21
08/05
16:07
08/05/21
16:07
PRTS

CarParts.com

$16.94 /

-0.18 (-1.05%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PRTS CarParts.com
$16.94 /

-0.18 (-1.05%)

PRTS CarParts.com
$16.94 /

-0.18 (-1.05%)

02/16/21 Craig-Hallum
CarParts.com price target raised to $28 from $20 at Craig-Hallum
11/12/20 RBC Capital
RBC Capital starts CarParts.com at Outperform with $15 price target
11/12/20 RBC Capital
CarParts.com initiated with an Outperform at RBC Capital
09/09/20 Roth Capital
CarParts.com re-initiated with a Buy at Roth Capital
PRTS CarParts.com
$16.94 /

-0.18 (-1.05%)

  • 14
    Aug
PRTS CarParts.com
$16.94 /

-0.18 (-1.05%)

PRTS CarParts.com
$16.94 /

-0.18 (-1.05%)

Earnings
Axonics raises FY21 revenue view to $186M-$188M, consensus $178.8MM » 16:07
08/05/21
08/05
16:07
08/05/21
16:07
AXNX

Axonics

$63.05 /

-3.18 (-4.80%)

Prior guidance was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXNX Axonics
$63.05 /

-3.18 (-4.80%)

AXNX Axonics
$63.05 /

-3.18 (-4.80%)

07/16/21 Barclays
Axonics recall of Bulkamid is not material, says Barclays
07/12/21
Fly Intel: Top five analyst initiations
07/12/21 Barclays
Axonics initiated with an Overweight at Barclays
05/07/21 Piper Sandler
Axonics price target raised to $75 from $70 at Piper Sandler
AXNX Axonics
$63.05 /

-3.18 (-4.80%)

  • 12
    May
Earnings
Insulet backs FY21 revenue growth view 16%-20%, consensus $1.08B  16:07
08/05/21
08/05
16:07
08/05/21
16:07
PODD

Insulet

$280.60 /

+1.235 (+0.44%)

 
ShowHide Related Items >><<
PODD Insulet
$280.60 /

+1.235 (+0.44%)

PODD Insulet
$280.60 /

+1.235 (+0.44%)

07/21/21 Cowen
Insulet price target raised to $310 from $285 at Cowen
05/27/21 Piper Sandler
Medtronic price target raised to $140 from $130 at Piper Sandler
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Insulet initiated with an Overweight at Barclays
PODD Insulet
$280.60 /

+1.235 (+0.44%)

PODD Insulet
$280.60 /

+1.235 (+0.44%)

Earnings
Turtle Beach still sees 2021 revenue $385M, consensus $385.06M » 16:06
08/05/21
08/05
16:06
08/05/21
16:06
HEAR

Turtle Beach

$28.70 /

-0.51 (-1.75%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

06/15/21 Oppenheimer
Turtle Beach price target raised to $45 from $40 at Oppenheimer
02/12/21 Maxim
Turtle Beach price target raised to $42 from $28 at Maxim
02/11/21 Stifel
Turtle Beach price target raised to $38 from $23.50 at Stifel
02/11/21 DA Davidson
Turtle Beach price target raised to $38 from $31 at DA Davidson
HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

Earnings
Insulet sees Q3 revenue growth 11%-18%, consensus $274.16M  16:06
08/05/21
08/05
16:06
08/05/21
16:06
PODD

Insulet

$280.57 /

+1.205 (+0.43%)

 
ShowHide Related Items >><<
PODD Insulet
$280.57 /

+1.205 (+0.43%)

PODD Insulet
$280.57 /

+1.205 (+0.43%)

07/21/21 Cowen
Insulet price target raised to $310 from $285 at Cowen
05/27/21 Piper Sandler
Medtronic price target raised to $140 from $130 at Piper Sandler
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Insulet initiated with an Overweight at Barclays
PODD Insulet
$280.57 /

+1.205 (+0.43%)

PODD Insulet
$280.57 /

+1.205 (+0.43%)

Earnings
Guardant Health sees FY21 revenue $360M-$370M, consensus $367.97M » 16:06
08/05/21
08/05
16:06
08/05/21
16:06
GH

Guardant Health

$115.04 /

+1.24 (+1.09%)

Due to continued…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GH Guardant Health
$115.04 /

+1.24 (+1.09%)

GH Guardant Health
$115.04 /

+1.24 (+1.09%)

06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
06/03/21
Fly Intel: Top five analyst initiations
GH Guardant Health
$115.04 /

+1.24 (+1.09%)

  • 07
    Oct
GH Guardant Health
$115.04 /

+1.24 (+1.09%)

Earnings
Axonics reports Q2 EPS (59c), consensus (49c) » 16:06
08/05/21
08/05
16:06
08/05/21
16:06
AXNX

Axonics

$62.98 /

-3.25 (-4.91%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AXNX Axonics
$62.98 /

-3.25 (-4.91%)

AXNX Axonics
$62.98 /

-3.25 (-4.91%)

07/16/21 Barclays
Axonics recall of Bulkamid is not material, says Barclays
07/12/21
Fly Intel: Top five analyst initiations
07/12/21 Barclays
Axonics initiated with an Overweight at Barclays
05/07/21 Piper Sandler
Axonics price target raised to $75 from $70 at Piper Sandler
AXNX Axonics
$62.98 /

-3.25 (-4.91%)

  • 12
    May
Earnings
Turtle Beach reports Q2 EPS 9c, consensus (10c) » 16:06
08/05/21
08/05
16:06
08/05/21
16:06
HEAR

Turtle Beach

$28.70 /

-0.51 (-1.75%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

06/15/21 Oppenheimer
Turtle Beach price target raised to $45 from $40 at Oppenheimer
02/12/21 Maxim
Turtle Beach price target raised to $42 from $28 at Maxim
02/11/21 Stifel
Turtle Beach price target raised to $38 from $23.50 at Stifel
02/11/21 DA Davidson
Turtle Beach price target raised to $38 from $31 at DA Davidson
HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

HEAR Turtle Beach
$28.70 /

-0.51 (-1.75%)

Earnings
Insulet reports Q2 EPS (37c), consensus 13c » 16:06
08/05/21
08/05
16:06
08/05/21
16:06
PODD

Insulet

$280.57 /

+1.205 (+0.43%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PODD Insulet
$280.57 /

+1.205 (+0.43%)

PODD Insulet
$280.57 /

+1.205 (+0.43%)

07/21/21 Cowen
Insulet price target raised to $310 from $285 at Cowen
05/27/21 Piper Sandler
Medtronic price target raised to $140 from $130 at Piper Sandler
05/25/21 Barclays
Barclays starts Medical Devices sector with Positive industry view
05/24/21 Barclays
Insulet initiated with an Overweight at Barclays
PODD Insulet
$280.57 /

+1.205 (+0.43%)

PODD Insulet
$280.57 /

+1.205 (+0.43%)

Earnings
Lionsgate reports Q1 adjusted EPS 18c, consensus (18c) » 16:06
08/05/21
08/05
16:06
08/05/21
16:06
LGF.A

Lionsgate

$14.70 /

+0.36 (+2.51%)

, LGF.B

Lionsgate

$13.25 /

+0.36 (+2.79%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LGF.A Lionsgate
$14.70 /

+0.36 (+2.51%)

LGF.B Lionsgate
$13.25 /

+0.36 (+2.79%)

LGF.A Lionsgate
$14.70 /

+0.36 (+2.51%)

07/22/21 Deutsche Bank
Lionsgate downgraded to Hold from Buy at Deutsche Bank
06/04/21 Barrington
Lionsgate price target raised to $27 from $16 at Barrington
06/01/21 Cowen
Lionsgate price target raised to $23 from $20 at Cowen
05/28/21 RBC Capital
Lionsgate price target raised to $17 from $13 at RBC Capital
LGF.B Lionsgate
$13.25 /

+0.36 (+2.79%)

06/01/21 Cowen
Lionsgate price target raised to $23 from $20 at Cowen
05/28/21 RBC Capital
Lionsgate price target raised to $17 from $13 at RBC Capital
05/26/21 Truist
Amazon's MGM deal 'a very modest negative' for Netflix/Disney, says Truist
05/26/21 Loop Capital
Lionsgate price target raised to $21 from $16 at Loop Capital
LGF.A Lionsgate
$14.70 /

+0.36 (+2.51%)

LGF.B Lionsgate
$13.25 /

+0.36 (+2.79%)

LGF.A Lionsgate
$14.70 /

+0.36 (+2.51%)

LGF.B Lionsgate
$13.25 /

+0.36 (+2.79%)

Earnings
Guardant Health reports Q2 adjusted EPS (61c), consensus (87c) » 16:06
08/05/21
08/05
16:06
08/05/21
16:06
GH

Guardant Health

$115.04 /

+1.24 (+1.09%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GH Guardant Health
$115.04 /

+1.24 (+1.09%)

GH Guardant Health
$115.04 /

+1.24 (+1.09%)

06/21/21 Wells Fargo
Guardant Health price target raised to $160 from $145 at Wells Fargo
06/15/21
Fly Intel: Top five analyst initiations
06/15/21 Raymond James
Guardant Health initiated with a Market Perform at Raymond James
06/03/21
Fly Intel: Top five analyst initiations
GH Guardant Health
$115.04 /

+1.24 (+1.09%)

  • 07
    Oct
GH Guardant Health
$115.04 /

+1.24 (+1.09%)

Upgrade
BCE upgraded to Buy from Hold at Canaccord » 16:05
08/05/21
08/05
16:05
08/05/21
16:05
BCE

BCE

$50.51 /

+0.78 (+1.57%)

Canaccord analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BCE BCE
$50.51 /

+0.78 (+1.57%)

BCE BCE
$50.51 /

+0.78 (+1.57%)

08/04/21 TD Securities
BCE price target raised to C$66 from C$63 at TD Securities
05/03/21 Desjardins
BCE price target raised to C$62 from C$61 at Desjardins
04/30/21 Canaccord
BCE price target raised to C$59 from C$58 at Canaccord
04/30/21 RBC Capital
BCE price target raised to C$60 from C$59 at RBC Capital
BCE BCE
$50.51 /

+0.78 (+1.57%)

BCE BCE
$50.51 /

+0.78 (+1.57%)

BCE BCE
$50.51 /

+0.78 (+1.57%)

Earnings
Oncternal Therapeutics reports Q2 EPS (16c), consensus (14c) » 16:05
08/05/21
08/05
16:05
08/05/21
16:05
ONCT

Oncternal Therapeutics

$3.87 /

+0.13 (+3.48%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ONCT Oncternal Therapeutics
$3.87 /

+0.13 (+3.48%)

ONCT Oncternal Therapeutics
$3.87 /

+0.13 (+3.48%)

04/06/21 Oppenheimer
Opco starts Oncternal at Outperform on 'compelling' lead asset data
04/06/21 Oppenheimer
Oncternal Therapeutics initiated with an Outperform at Oppenheimer
03/30/21
Fly Intel: Top five analyst initiations
03/30/21 Brookline
Oncternal Therapeutics initiated with a Buy at Brookline
ONCT Oncternal Therapeutics
$3.87 /

+0.13 (+3.48%)

  • 18
    Nov
  • 28
    Aug
ONCT Oncternal Therapeutics
$3.87 /

+0.13 (+3.48%)

ONCT Oncternal Therapeutics
$3.87 /

+0.13 (+3.48%)

Earnings
Apollo Investment reports Q2 EPS 49c, consensus 39c » 16:05
08/05/21
08/05
16:05
08/05/21
16:05
AINV

Apollo Investment

$13.69 /

+0.08 (+0.59%)

As of June 30, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AINV Apollo Investment
$13.69 /

+0.08 (+0.59%)

AINV Apollo Investment
$13.69 /

+0.08 (+0.59%)

05/24/21
Fly Intel: Top five analyst downgrades
05/24/21 Wells Fargo
Wells Fargo downgrades Apollo Investment with de-leveraging complete
05/24/21 Wells Fargo
Apollo Investment downgraded to Equal Weight from Overweight at Wells Fargo
11/10/20 Wells Fargo
Wells Fargo double upgrades Apollo Investment to Overweight on lower leverage
AINV Apollo Investment
$13.69 /

+0.08 (+0.59%)

Earnings
ViewRay sees 2021 revenue $63M-$73M, consensus $73.15M  16:05
08/05/21
08/05
16:05
08/05/21
16:05
VRAY

ViewRay

$6.89 /

+0.1 (+1.47%)

 
ShowHide Related Items >><<
VRAY ViewRay
$6.89 /

+0.1 (+1.47%)

VRAY ViewRay
$6.89 /

+0.1 (+1.47%)

06/25/21 Morgan Stanley
ViewRay upgraded to Equal Weight from Underweight at Morgan Stanley
06/25/21 B. Riley
ViewRay announced 'most significant' purchase agreement, says B. Riley
06/14/21 Piper Sandler
ViewRay shares should attract more investor interest, says Piper Sandler
05/07/21 Guggenheim
ViewRay upgraded to Buy from Neutral at Guggenheim
VRAY ViewRay
$6.89 /

+0.1 (+1.47%)

  • 22
    Jan
  • 05
    Jan
Earnings
Mirum Pharmaceuticals reports Q2 EPS ($1.45), consensus (65c) » 16:05
08/05/21
08/05
16:05
08/05/21
16:05
MIRM

Mirum Pharmaceuticals

$14.62 /

-0.05 (-0.34%)

Licensing revenue for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MIRM Mirum Pharmaceuticals
$14.62 /

-0.05 (-0.34%)

MIRM Mirum Pharmaceuticals
$14.62 /

-0.05 (-0.34%)

03/29/21 Piper Sandler
Piper says Mirum approval for Alagille syndrome 'in the bag'
02/08/21 SVB Leerink
Mirum Pharmaceuticals initiated with an Outperform at SVB Leerink
02/01/21 Piper Sandler
Piper says FDA 'very unlikely' to require AdCom for Mirum's maralixibat in ALGS
12/09/20 Piper Sandler
Mirum Pharmaceuticals investor day highlights pipeline advances, says Piper
MIRM Mirum Pharmaceuticals
$14.62 /

-0.05 (-0.34%)

  • 15
    Dec
Earnings
Alarm.com raises FY21 EPS view to $1.77-$1.79 from $1.63-$1.72 » 16:04
08/05/21
08/05
16:04
08/05/21
16:04
ALRM

Alarm.com

$85.34 /

+0.84 (+0.99%)

Consensus $1.68. Raises…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALRM Alarm.com
$85.34 /

+0.84 (+0.99%)

ALRM Alarm.com
$85.34 /

+0.84 (+0.99%)

07/12/21
Fly Intel: Top five analyst initiations
07/12/21 Barclays
Alarm.com initiated with an Equal Weight at Barclays
04/08/21 Imperial Capital
Alarm.com price target raised to $105 from $100 at Imperial Capital
04/06/21 JPMorgan
Alarm.com initiated with a Neutral at JPMorgan
ALRM Alarm.com
$85.34 /

+0.84 (+0.99%)

ALRM Alarm.com
$85.34 /

+0.84 (+0.99%)

Earnings
ViewRay reports Q2 EPS (19c), consensus (16c) » 16:04
08/05/21
08/05
16:04
08/05/21
16:04
VRAY

ViewRay

$6.89 /

+0.1 (+1.47%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRAY ViewRay
$6.89 /

+0.1 (+1.47%)

VRAY ViewRay
$6.89 /

+0.1 (+1.47%)

06/25/21 Morgan Stanley
ViewRay upgraded to Equal Weight from Underweight at Morgan Stanley
06/25/21 B. Riley
ViewRay announced 'most significant' purchase agreement, says B. Riley
06/14/21 Piper Sandler
ViewRay shares should attract more investor interest, says Piper Sandler
05/07/21 Guggenheim
ViewRay upgraded to Buy from Neutral at Guggenheim
VRAY ViewRay
$6.89 /

+0.1 (+1.47%)

  • 22
    Jan
  • 05
    Jan
Hot Stocks
Cornerstone OnDemand to be acquired by Clearlake for $57.50 per share in cash  16:04
08/05/21
08/05
16:04
08/05/21
16:04
CSOD

Cornerstone OnDemand

$49.86 /

+0.38 (+0.77%)

 
ShowHide Related Items >><<
CSOD Cornerstone OnDemand
$49.86 /

+0.38 (+0.77%)

CSOD Cornerstone OnDemand
$49.86 /

+0.38 (+0.77%)

06/30/21 Berenberg
Cornerstone OnDemand initiated with a Buy at Berenberg
05/07/21 BMO Capital
Cornerstone OnDemand price target lowered to $50 from $63 at BMO Capital
04/27/21 JMP Securities
Workday price target raised to $310 from $296 at JMP Securities
03/26/21 DA Davidson
DA Davidson sees 'material' COVID tailwinds for Cornerstone OnDemand
CSOD Cornerstone OnDemand
$49.86 /

+0.38 (+0.77%)

CSOD Cornerstone OnDemand
$49.86 /

+0.38 (+0.77%)

Earnings
Alarm.com sees Q3 SaaS and license revenue $114.9M-$115.1M  16:03
08/05/21
08/05
16:03
08/05/21
16:03
ALRM

Alarm.com

$85.37 /

+0.87 (+1.03%)

 
ShowHide Related Items >><<
ALRM Alarm.com
$85.37 /

+0.87 (+1.03%)

ALRM Alarm.com
$85.37 /

+0.87 (+1.03%)

07/12/21
Fly Intel: Top five analyst initiations
07/12/21 Barclays
Alarm.com initiated with an Equal Weight at Barclays
04/08/21 Imperial Capital
Alarm.com price target raised to $105 from $100 at Imperial Capital
04/06/21 JPMorgan
Alarm.com initiated with a Neutral at JPMorgan
ALRM Alarm.com
$85.37 /

+0.87 (+1.03%)

ALRM Alarm.com
$85.37 /

+0.87 (+1.03%)

Earnings
FireEye reports Q2 EPS (14c), consensus 9c » 16:03
08/05/21
08/05
16:03
08/05/21
16:03
FEYE

FireEye

$20.11 /

-0.35 (-1.71%)

Reports Q2 revenue $114M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FEYE FireEye
$20.11 /

-0.35 (-1.71%)

FEYE FireEye
$20.11 /

-0.35 (-1.71%)

07/16/21 Mizuho
FireEye price target lowered to $21 from $23 at Mizuho
07/08/21 Barclays
FireEye price target lowered to $20 from $22 at Barclays
06/03/21 Baird
FireEye rebranding reduces financial visibility, says Baird
06/03/21 Morgan Stanley
FireEye break up makes sense, but upside 'less clear,' says Morgan Stanley
FEYE FireEye
$20.11 /

-0.35 (-1.71%)

FEYE FireEye
$20.11 /

-0.35 (-1.71%)

FEYE FireEye
$20.11 /

-0.35 (-1.71%)

FEYE FireEye
$20.11 /

-0.35 (-1.71%)

Earnings
Alarm.com reports Q2 adjusted EPS 54c, consensus 39c » 16:03
08/05/21
08/05
16:03
08/05/21
16:03
ALRM

Alarm.com

$85.37 /

+0.87 (+1.03%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALRM Alarm.com
$85.37 /

+0.87 (+1.03%)

ALRM Alarm.com
$85.37 /

+0.87 (+1.03%)

07/12/21
Fly Intel: Top five analyst initiations
07/12/21 Barclays
Alarm.com initiated with an Equal Weight at Barclays
04/08/21 Imperial Capital
Alarm.com price target raised to $105 from $100 at Imperial Capital
04/06/21 JPMorgan
Alarm.com initiated with a Neutral at JPMorgan
ALRM Alarm.com
$85.37 /

+0.87 (+1.03%)

ALRM Alarm.com
$85.37 /

+0.87 (+1.03%)

Earnings
Cornerstone OnDemand reports Q2 EPS 73c , consensus 52c » 16:03
08/05/21
08/05
16:03
08/05/21
16:03
CSOD

Cornerstone OnDemand

$49.94 /

+0.46 (+0.93%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSOD Cornerstone OnDemand
$49.94 /

+0.46 (+0.93%)

CSOD Cornerstone OnDemand
$49.94 /

+0.46 (+0.93%)

06/30/21 Berenberg
Cornerstone OnDemand initiated with a Buy at Berenberg
05/07/21 BMO Capital
Cornerstone OnDemand price target lowered to $50 from $63 at BMO Capital
04/27/21 JMP Securities
Workday price target raised to $310 from $296 at JMP Securities
03/26/21 DA Davidson
DA Davidson sees 'material' COVID tailwinds for Cornerstone OnDemand
CSOD Cornerstone OnDemand
$49.94 /

+0.46 (+0.93%)

CSOD Cornerstone OnDemand
$49.94 /

+0.46 (+0.93%)

Hot Stocks
Expedia reports Q2 gross bookings $20.82B, up 667% y/y  16:03
08/05/21
08/05
16:03
08/05/21
16:03
EXPE

Expedia

$161.09 /

+7.8 (+5.09%)

 
ShowHide Related Items >><<
EXPE Expedia
$161.09 /

+7.8 (+5.09%)

EXPE Expedia
$161.09 /

+7.8 (+5.09%)

05/26/21 RBC Capital
Expedia assumed with a Sector Perform at RBC Capital
05/12/21 Citi
Expedia price target raised to $179 from $160 at Citi
05/07/21 BTIG
Expedia price target raised to $210 from $180 at BTIG
05/07/21 Credit Suisse
Expedia price target raised to $198 from $168 at Credit Suisse
EXPE Expedia
$161.09 /

+7.8 (+5.09%)

EXPE Expedia
$161.09 /

+7.8 (+5.09%)

EXPE Expedia
$161.09 /

+7.8 (+5.09%)

EXPE Expedia
$161.09 /

+7.8 (+5.09%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.